Cargando…
Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide
BACKGROUND: Patients with acute-onset symptomatic atrial fibrillation (AF) can be treated with flecainide. However, flecainide may induce arrhythmias and/or exaggerate heart failure. Therefore, validated markers to predict the efficacy of flecainide and prevent adverse effects are required. We hypot...
Autores principales: | Amin, Ahmad Shoaib, Peters, René H.J., Verstraaten, Maaike, Wilde, Arthur A.M., Buijs, Eugène M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352147/ https://www.ncbi.nlm.nih.gov/pubmed/25884086 http://dx.doi.org/10.1007/s12471-015-0659-8 |
Ejemplares similares
-
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge
por: Schellings, D. A. A. M., et al.
Publicado: (2016) -
Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013) -
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010) -
The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)